• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease--a hypothesis.

作者信息

Förstl H, Levy R, Burns A, Luthert P, Cairns N

机构信息

Central Institute of Mental Health, Department of Psychiatry, Mannheim, Germany.

出版信息

Pharmacopsychiatry. 1994 Jan;27(1):11-5. doi: 10.1055/s-2007-1014267.

DOI:10.1055/s-2007-1014267
PMID:8159776
Abstract

Forty-two patients with neuropathologically confirmed Alzheimer's disease, who had been examined prospectively, had a significant decrease of neuron numbers in the locus coeruleus, substantia nigra, and basal nucleus of Meynert compared to 10 age-matched, non-demented controls. A subgroup of 12 demented patients with a history of depression had significantly lower neuron numbers in the locus coeruleus and slightly higher neuronal density in the basal nucleus of Meynert. We hypothesize that a noradrenergic/cholinergic imbalance may promote the development of depressive features in patients with Alzheimer's disease.

摘要

相似文献

1
Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease--a hypothesis.
Pharmacopsychiatry. 1994 Jan;27(1):11-5. doi: 10.1055/s-2007-1014267.
2
[Organic correlates of depressive symptoms in Alzheimer's dementia. Results of a prospective study, review of the literature].[阿尔茨海默病性痴呆中抑郁症状的器质性关联。一项前瞻性研究的结果,文献综述]
Nervenarzt. 1992 Sep;63(9):566-74.
3
Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.利用磁共振成像测量阿尔茨海默病患者的基底前脑萎缩情况。
Brain. 2005 Nov;128(Pt 11):2626-44. doi: 10.1093/brain/awh589. Epub 2005 Jul 13.
4
Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.帕金森病和阿尔茨海默病中迈内特基底核神经元丢失的临床和神经化学后果。
Adv Neurol. 1987;45:393-7.
5
Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.在阿尔茨海默病和帕金森病所致痴呆中,甘丙肽对人类迈内特基底核存活神经元的神经支配增加:甘丙肽在加重痴呆中胆碱能功能障碍作用的一种假说。
J Comp Neurol. 1988 Jul 22;273(4):543-57. doi: 10.1002/cne.902730409.
6
A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.阿尔茨海默病中基底核与蓝斑核变化的比较。
J Neurol Neurosurg Psychiatry. 1984 Feb;47(2):201-3. doi: 10.1136/jnnp.47.2.201.
7
The cholinergic deficit in Alzheimer's disease.阿尔茨海默病中的胆碱能缺陷。
J Clin Psychiatry. 1998;59 Suppl 13:19-22.
8
A review of neuropathological and neurochemical correlates of Alzheimer's disease.阿尔茨海默病的神经病理学与神经化学相关性综述。
Dan Med Bull. 1985 Feb;32 Suppl 1:27-34.
9
Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease.老年特发性帕金森病患者痴呆的病理基础
Eur Neurol. 1988;28 Suppl 1:29-35.
10
Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.阿尔茨海默病患者纹状体和基底前脑胆碱能神经元中TrkA基因表达降低。
Exp Neurol. 1997 May;145(1):245-52. doi: 10.1006/exnr.1997.6443.

引用本文的文献

1
Catecholaminergic nucleus integrity and Alzheimer's pathology, symptoms, and progression.儿茶酚胺能核团完整性与阿尔茨海默病的病理、症状及进展
Alzheimers Dement. 2025 Oct;21(10):e70749. doi: 10.1002/alz.70749.
2
Beyond the brain: early autonomic dysfunction in Alzheimer's disease.超越大脑:阿尔茨海默病早期的自主神经功能障碍
Acta Neuropathol Commun. 2025 Jun 10;13(1):128. doi: 10.1186/s40478-025-02042-8.
3
Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.神经血管单元功能障碍、认知障碍和阿尔茨海默病的外周通路
Front Aging Neurosci. 2022 Apr 18;14:858429. doi: 10.3389/fnagi.2022.858429. eCollection 2022.
4
New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease.用于阿尔茨海默病去甲肾上腺素能功能障碍定量和靶向的新方法。
Ann Clin Transl Neurol. 2022 Apr;9(4):582-596. doi: 10.1002/acn3.51539. Epub 2022 Mar 15.
5
Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?基底核内 Meynert 核的线性测量是否适合作为轻度认知障碍和阿尔茨海默病的诊断生物标志物?
AJNR Am J Neuroradiol. 2019 Dec;40(12):2039-2044. doi: 10.3174/ajnr.A6313. Epub 2019 Nov 14.
6
Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.阿尔茨海默病中的复杂去甲肾上腺素能功能障碍:低去甲肾上腺素输入并不总是罪魁祸首。
Brain Res. 2019 Jan 1;1702:12-16. doi: 10.1016/j.brainres.2018.01.001. Epub 2018 Jan 4.
7
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.蓝斑核在阿尔茨海默病进展过程中的细胞和分子病理学。
Acta Neuropathol Commun. 2017 Jan 21;5(1):8. doi: 10.1186/s40478-017-0411-2.
8
Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.功能失调的感觉模态、蓝斑和基底前脑:促进认知和记忆衰退以及阿尔茨海默病神经病理发生的早期决定因素。
Neurotox Res. 2016 Oct;30(3):295-337. doi: 10.1007/s12640-016-9643-3. Epub 2016 Jun 23.
9
Noradrenergic dysfunction in Alzheimer's disease.阿尔茨海默病中的去甲肾上腺素能功能障碍。
Front Neurosci. 2015 Jun 17;9:220. doi: 10.3389/fnins.2015.00220. eCollection 2015.
10
Early neurone loss in Alzheimer's disease: cortical or subcortical?阿尔茨海默病中的早期神经元丧失:皮质还是皮质下?
Acta Neuropathol Commun. 2015 Feb 10;3:10. doi: 10.1186/s40478-015-0187-1.